Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes
Open Access
- 6 June 2006
- journal article
- research article
- Published by Springer Nature in International Journal of Obesity
- Vol. 31 (2) , 213-220
- https://doi.org/10.1038/sj.ijo.0803355
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Metabolic Syndrome Scientific Statement by the American Heart Association and the National Heart, Lung, and Blood InstituteArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistanceDiabetic Medicine, 2005
- Adiponectin Concentrations Are Influenced by Renal Function and Diabetes Duration in Pima Indians with Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2004
- Are Kuwaitis Getting Fatter?Nutrition and Health, 2003
- Inflammatory Markers, Adiponectin, and Risk of Type 2 Diabetes in the Pima IndianDiabetes Care, 2003
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Adiponectin is not altered with exercise training despite enhanced insulin actionAmerican Journal of Physiology-Endocrinology and Metabolism, 2002
- Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and HyperinsulinemiaJournal of Clinical Endocrinology & Metabolism, 2001
- Comment on the provisional report from the WHO consultationDiabetic Medicine, 1999
- The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010Diabetic Medicine, 1997